Skip to content

Mark S Schmidt

3 papers in the library · 153 citations · publishing 2004-2005

Papers

Sort Most recent Most cited

Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates.

Synapse December 1, 2005 Matthew Schmidt, Mark S Schmidt, Eduardo R Butelman et al. 85 citations

Salvinorin A, a potent hallucinogen isolated from the leaves of Salvia divinorum, has gained popularity among adolescents in the USA. No detailed study of the pharmacokinetics has been conducted in vivo. The present study investigates the in vivo pharmacokinetics of salvinorin A (0.032 mg/kg, i.v. bolus) in rhesus monkeys (n=4, 2 male, 2 female). The elimination t(1/2) was rapid (56.6+/-24.8...

DOI: 10.1002/syn.20191 (opens in new tab) Full text (opens in new tab) Salvinorin a Plant hallucinogen Psychoactive substance Pharmacokinetics +16

A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A.

Bioorganic & Medicinal Chemistry Letters October 18, 2004 Kevin Tidgewell, Wayne W Harding, Mark S Schmidt et al. 68 citations

Salvinorin A is a novel hallucinogen isolated from the widely available leaves of Salvia divinorum. Based on its mechanism of action, salvinorin A has shown potential as a stimulant abuse therapeutic. However, there are no methods for the detection of salvinorin A or its metabolites in biological fluids. In order to begin developing salvinorin A as a potential therapeutic, an understanding of...

DOI: 10.1016/j.bmcl.2004.07.081 (opens in new tab) Full text (opens in new tab) Salvinorin a Drug metabolism Analytical methods Therapeutic potential